Resolution Chemicals Limited v. Astrazeneca B.V. and Shionogi Seiyaku Kabushiki Kaisha, District Court The Hague, 15 July 2015, Case No. HA ZA 14-738
Resolution successfully argues that Shionogi's SPC is partially invalid. The SPC is invalid in as far as it concerns other products than the non-toxic pharmaceutically acceptable salts of rosuvastatine named in base patent EP 471.
Read the decision (in Dutch) here.